Tweet
Cureus
. 2022 Jul 9;14(7):e26673.
doi: 10.7759/cureus.26673. eCollection 2022 Jul.
A Young Lady With Myopericarditis: An Unusual Presentation of COVID-19 Infection
Md Nazmul Hasan 1 , Adrita Afzal 2 , Chowdhury Adnan Sami 1 , Fazle R Chowdhury 1 , Din-E-Mujahid M Faruque 3
Affiliations
- PMID: 35949764
- PMCID: PMC9358309
- DOI: 10.7759/cureus.26673
Abstract
Fever, sore throat, cough, and shortness of breath are the characteristic clinical manifestations of coronavirus disease 2019 (COVID-19). As the epidemic spreads, it is evident that the infection can affect not only the lungs but also other organs. By attaching to the angiotensin-converting enzyme-2 receptor (ACE-2), the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces lung injury. SARS-CoV-2 can also cause damage to the heart and blood vessels as these organs have abundant ACE-2 receptors. Here, we present a 28-year-old lady with shortness of breath, chest pain, low blood pressure, and a pulse rate that fluctuates widely. She had SARS-CoV-2-induced myopericarditis after further testing. Initially, we treated her with high-dose prednisolone and other supportive medications. Then, we also added colchicine and ibuprofen due to the initial poor response, and the result was satisfying after two weeks of treatment.
Keywords: colchicine in myopericarditis; covid-19; myopericarditis; sars-cov-2; successfully treated myopericarditis.